Chief Medical Innovation Advisor - Healthcare Executive Advisory Board Member

About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) + Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and brain fog from Long COVID. This is not about research. This is about treating patients. ATCA goes beyond diagnosing Alzheimer’s and dementia to uncover and address root causes through our innovative treatment protocols. Our multidisciplinary team, which includes top business executives and medical professionals with expertise in virtual reality and artificial intelligence, is leading the rollout of ATCA Clinics across the U.S.

Why Now? Immediate Revenue: ATCA is expanding to a multi-clinic organisation incorporating a new prime location...We're Launching Our New Clinic in Palm Beach Gardens, Florida. The Alzheimer's Treatment Centers of America ATCA clinic Palm Beach Gardens/Jupiter is located on the first floor of a two storey building with the Cleveland Clinic as a neighboring tenant. It is located in one of the most affluent areas and has replaced a prior urgent care space which has resulted in high levels of uptake with appointments already booked as far as March. In-Network with Insurance: ATCA treatments are covered by Medicare, Medicare Advantage, and most major healthcare insurance providers. Proven Results: In a study using the AI protocol implemented by ATCA, 75% of patients with mild cognitive impairment experienced no further decline. FDA-Approved Treatment: Includes TB006, which is FDA-approved for compassionate use and has the potential to reverse dementias, including Alzheimer’s. Physician-Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. See our Medical Advisory Board:

https://atca.ai/medical-advisory-board/

Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams.

Chief Medical Innovation Advisor Job Description ATCA is seeking a visionary Chief Medical Innovation Advisor to join its Medical Advisory Board and help guide the evolution of a next-generation treatment model for Alzheimer’s disease and cognitive decline. This role is designed for senior physician-leaders and healthcare innovators with deep experience advancing clinical innovation, translating emerging science into real-world care, and scaling novel treatment models across healthcare systems. As Chief Medical Innovation Advisor, you will play a key role in shaping how AI, precision medicine, and advanced therapeutics are responsibly integrated into ATCA’s clinical platform. You will work closely with ATCA’s executive leadership, clinical directors, research collaborators, and data science teams to refine innovation strategy, validate new approaches, and ensure that innovation directly translates into improved patient outcomes and scalable care delivery.

Responsibilities Include Clinical Innovation Strategy: Provide strategic guidance on the development, evaluation, and deployment of innovative clinical approaches, technologies, and therapies within ATCA’s treatment model. AI & Precision Medicine Leadership: Advise on the responsible integration of AI-driven diagnostics, predictive analytics, and personalized treatment protocols into clinical workflows. Translational Medicine Oversight: Support the translation of emerging research, novel therapeutics, and clinical insights into practical, scalable treatment pathways. Innovation Governance & Prioritization: Help establish frameworks for evaluating, prioritizing, and scaling new clinical innovations while maintaining patient safety and regulatory compliance. Cross-Functional Collaboration: Collaborate with physicians, scientists, technologists, and business leaders to align innovation initiatives with clinical needs and operational realities. Outcome Evaluation & Continuous Improvement: Review aggregated, de-identified outcomes data to assess the impact of innovation initiatives and guide continuous clinical improvement. External Innovation & Partnerships: Provide insight into strategic partnerships, academic collaborations, and technology alliances that may accelerate ATCA’s innovation roadmap.

Why Join Us? Transform Patient Outcomes: Help advance a model of Alzheimer’s care that prioritizes early detection, prevention, and coordinated primary care involvement. Influence National Care Delivery: Play a meaningful role in shaping how primary care–informed cognitive care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where primary care leadership directly impacts growth, outcomes, and legacy.

Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role.

Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.